___

• 1. Kumar V, Abbas AK, Fausto N, Aster JC (2014) Robbins and Cotran pathologic basis of disease, professional edition e-book: Elsevier health sciences. 2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, et al. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136: E359-386. 3. Saatçi E (2014) Dünyada ve Türkiye'de Kanser Epidemiyolojisi. Turkiye Klinikleri Family Medicine-Special Topics 5: 1-8. 4. Gultekin M, Utku E, Ergun A, Sevinc A, Tutuncu S, et al. (2015) Turkiye Kanser Istatistikleri (Cancer Statistics in Turkey). TC Saglik Bakanligi, Türkiye Halk Sağlığı Kurumu (Turkish Organization for Public Health), Ankara, Turkey. 5. Stewart TA, Yapa KT, Monteith GR (2015) Altered calcium signaling in cancer cells. Biochim Biophys Acta 1848: 2502-2511. 6. Yu S, Huang S, Ding Y, Wang W, Wang A, et al. (2019) Transient receptor potential ion-channel subfamily V member 4: a potential target for cancer treatment. Cell Death Dis 10: 497. 7. Thoppil RJ, Adapala RK, Cappelli HC, Kondeti V, Dudley AC, et al. (2015) TRPV4 channel activation selectively inhibits tumor endothelial cell proliferation. Sci Rep 5: 14257. 8. Peters AA, Jamaludin SYN, Yapa K, Chalmers S, Wiegmans AP,et al. (2017) Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells. Oncogene 36: 6490-6500. 9. Lee WH, Choong LY, Jin TH, Mon NN, Chong S, et al. (2017) TRPV4 plays a role in breast cancer cell migration via Ca(2+)-dependent activation of AKT and downregulation of E-cadherin cell cortex protein. Oncogenesis 6: 39. 10. Thoppil RJ, Cappelli HC, Adapala RK, Kanugula AK, Paruchuri S, et al. (2016) TRPV4 channels regulate tumor angiogenesis via modulation of Rho/Rho kinase pathway. Oncotarget 7: 25849-25861.